Literature DB >> 20695979

The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo.

B De Maeyer1, S F De Meyer, H B Feys, I Pareyn, N Vandeputte, H Deckmyn, K Vanhoorelbeke.   

Abstract

BACKGROUND: The multidomain metalloprotease ADAMTS13 regulates the size of von Willebrand factor (VWF) multimers upon their release from endothelial cells. How the different domains in ADAMTS13 control VWF proteolysis in vivo remains largely unidentified.
METHODS: Seven C-terminally truncated murine ADAMTS13 (mADAMTS13) mutants were constructed and characterized in vitro. Their ability to cleave VWF strings in vivo was studied in the ADAMTS13(-/-) mouse.
RESULTS: Murine MDTCS (devoid of T2-8 and CUB domains) retained full enzyme activity in vitro towards FRETS-VWF73 and the C-terminal T6-8 (del(T6-CUB)) and CUB domains (delCUB) are dispensable under these assay conditions. In addition, mADAMTS13 fragments without the spacer domain (MDT and M) had reduced catalytic efficiencies. Our results hence indicate that similar domains in murine and human ADAMTS13 are required for activity in vitro, supporting the use of mouse models to study ADAMTS13 function in vivo. Interestingly, using intravital microscopy we show that removal of the CUB domains abolishes proteolysis of platelet-decorated VWF strings in vivo. In addition, whereas MDTCS is fully active in vivo, partial (del(T6-CUB)) or complete (delCUB) addition of the T2-8 domains gradually attenuates its activity.
CONCLUSIONS: Our data demonstrate that the ADAMTS13 CUB and T2-8 domains influence proteolysis of platelet-decorated VWF strings in vivo.
© 2010 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20695979     DOI: 10.1111/j.1538-7836.2010.04008.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  11 in total

1.  Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Authors:  Miruna Popa; Sibgha Tahir; Julia Elrod; Su Hwan Kim; Florian Leuschner; Thorsten Kessler; Peter Bugert; Ulrich Pohl; Andreas H Wagner; Markus Hecker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-23       Impact factor: 11.205

Review 2.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

3.  Single particle tracking of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type-1 repeats) molecules on endothelial von Willebrand factor strings.

Authors:  Karen De Ceunynck; Susana Rocha; Simon F De Meyer; J Evan Sadler; Hiroshi Uji-i; Hans Deckmyn; Johan Hofkens; Karen Vanhoorelbeke
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

4.  Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.

Authors:  Juan Xiao; Sheng-Yu Jin; Jing Xue; Nicoletta Sorvillo; Jan Voorberg; X Long Zheng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-28       Impact factor: 8.311

5.  Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model.

Authors:  Sheng-Yu Jin; Junichiro Tohyama; Robert C Bauer; Na Nora Cao; Daniel J Rader; X Long Zheng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-31       Impact factor: 8.311

6.  Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.

Authors:  Simon F De Meyer; Alexander S Savchenko; Michael S Haas; Daphne Schatzberg; Michael C Carroll; Alexandra Schiviz; Barbara Dietrich; Hanspeter Rottensteiner; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

7.  AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura.

Authors:  Sheng-Yu Jin; Juan Xiao; Jialing Bao; Shangzhen Zhou; J Fraser Wright; X Long Zheng
Journal:  Blood       Date:  2013-03-20       Impact factor: 22.113

Review 8.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

9.  Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.

Authors:  Louis Deforche; Claudia Tersteeg; Elien Roose; Aline Vandenbulcke; Nele Vandeputte; Inge Pareyn; Elien De Cock; Hanspeter Rottensteiner; Hans Deckmyn; Simon F De Meyer; Karen Vanhoorelbeke
Journal:  PLoS One       Date:  2016-08-01       Impact factor: 3.240

10.  A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation.

Authors:  Frédéric Adam; Caterina Casari; Nicolas Prévost; Alexandre Kauskot; Cécile Loubière; Paulette Legendre; Christelle Repérant; Dominique Baruch; Jean-Philippe Rosa; Marijke Bryckaert; Philip G de Groot; Olivier D Christophe; Peter J Lenting; Cécile V Denis
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.